about
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsPercutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patientsIs Multiple Sclerosis an Autoimmune Disease?Variants of ST8SIA1 are associated with risk of developing multiple sclerosis.Anomalous venous blood flow and iron deposition in multiple sclerosis.Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders.Prevalence study of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: preliminary data.Endovascular therapy for chronic cerebrospinal venous insufficiency in multiple sclerosisThe double-edged sword of autoimmunity: lessons from multiple sclerosis.Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis.MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum.Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination.Vitamin D₃ and monomethyl fumarate enhance natural killer cell lysis of dendritic cells and ameliorate the clinical score in mice suffering from experimental autoimmune encephalomyelitis.Growth hormone response to clonidine administration for evaluation of autonomic dysfunction in multiple sclerosis patients.Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesisIdentification of Tmem10 as a novel late-stage oligodendrocytes marker for detecting hypomyelination.Activation of Blood CD3+CD56+CD8+ T Cells during Pregnancy and Multiple Sclerosis.Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment.Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness.Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis.Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.Ciliary neurotrophic factor role in myelin oligodendrocyte glycoprotein expression in Cuprizone-induced multiple sclerosis mice.Neck duplex Doppler ultrasound evaluation for assessing chronic cerebrospinal venous insufficiency in multiple sclerosis patients.Fungal infection in a patient with multiple sclerosis.Role of Natural Killer Cells in Multiple Sclerosis
P2860
Q24202111-1096BC6B-DED6-4BC6-B475-10E9BD46E1B4Q24202967-79096183-F062-4F90-A66E-53850A5F2D4BQ27496011-D501D11A-7B02-4863-93C5-738E3EBA7E24Q33350182-D9F5DFA9-4118-428C-A98F-A91FB38C7B70Q33499203-3532F2C9-4F07-4957-A11A-A3A77B7D1E87Q33674644-98DC09A1-EBC3-4AD9-9C44-D3487FAE29A5Q34121504-6B45DEA6-6C1B-48A6-B93A-81742ED6A7BAQ35113791-E44527CB-A894-478F-A495-989B46507DBAQ35155753-73BC71AE-606A-477E-9F4D-9919C0D6B188Q35318380-35185C2A-6AE9-47B9-9039-66843106CE63Q36154032-12A8B5C8-5DF2-432D-A714-B58A59DE529EQ36299698-2F87E847-3296-4525-9E3C-EB7CAB03F272Q36329622-64FD958B-FA21-4650-B820-3115BC414F6DQ37111652-30C90BF6-DD3F-4E8E-8CBD-6FA481E68DB2Q37130888-7CA04900-2614-4248-9FA2-0720E7BA9D2DQ37428741-A524B3DB-8F0A-43EB-978B-E39B746F543BQ37660924-266232E6-1A23-4499-A6CD-57C72D165EF8Q41486306-D88B9D13-6633-49E6-A390-F2DF48FB3858Q41528091-B97DB2D7-A318-4E0C-8D5F-6EA320523CE4Q41574108-D78AFAD2-A5F6-4A9F-BEFE-36AC111DDEF2Q41877062-19325406-B8EF-435E-B7DB-A4EE0CA45BB0Q45051419-1408FDE0-E72E-4722-8CAF-FAF22FBAA33AQ45690450-892CE415-3E9E-40AF-AFC3-62D5617FDC44Q48147650-BE03A90B-E74A-47F8-B59F-3BCBC0609C2CQ48647280-07338394-EDCA-41ED-A3E3-824AC5CDFC5CQ54375281-F31B1B58-8D12-447F-86D1-FCF2BD01B123Q58692418-E2A82659-605C-4FBE-8768-736F18ECBC12
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The pathology of multiple sclerosis: a paradigm shift.
@ast
The pathology of multiple sclerosis: a paradigm shift.
@en
type
label
The pathology of multiple sclerosis: a paradigm shift.
@ast
The pathology of multiple sclerosis: a paradigm shift.
@en
prefLabel
The pathology of multiple sclerosis: a paradigm shift.
@ast
The pathology of multiple sclerosis: a paradigm shift.
@en
P1476
The pathology of multiple sclerosis: a paradigm shift.
@en
P2093
Ian Sutton
Michael H Barnett
P304
P356
10.1097/01.WCO.0000227032.47458.CB
P577
2006-06-01T00:00:00Z